{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:53:14Z","timestamp":1792036394437,"version":"4.4.0"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T00:00:00Z","timestamp":1674691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Abdominal aortic aneurysms (AAA) are characterized by vascular inflammation and remodeling that can lead to aortic rupture resulting in significant mortality. Pannexin-1 channels on endothelial cells (ECs) can modulate ATP secretion to regulate the pathogenesis of AAA formation. Our hypothesis focused on potential of spironolactone to inhibit EC-mediated ATP release for the mitigation of AAA formation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A topical elastase AAA model was used initially in C57BL\/6 (wild-type; WT) male mice. Mice were administered either a vehicle control (saline) or spironolactone and analyzed on day 14. In a second chronic AAA model, mice were subjected to elastase and \u03b2-aminopropionitrile (BAPN) treatment with\/without administration of spironolactone to pre-formed aneurysms starting on day 14 and analyzed on day 28. Aortic diameter was evaluated by video micrometry and aortic tissue was analyzed for cytokine expression and histology. ATP measurement and matrix metalloproteinase (MMP2) activity was evaluated in aortic tissue on days 14 or -28. <jats:italic>In vitro<\/jats:italic> studies were performed to evaluate the crosstalk between aortic ECs with macrophages or smooth muscle cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In the elastase AAA model, spironolactone treatment displayed a significant decrease in aortic diameter compared to elastase-treated controls on day 14. A significant increase in smooth muscle \u03b1-actin expression as well as decrease in elastic fiber disruption and immune cell (macrophages and neutrophils) infiltration was observed in mice treated with spironolactone compared to saline-treated controls. Spironolactone treatment also significantly mitigated pro-inflammatory cytokine expression, MMP2 activity and ATP content in aortic tissue compared to controls. Moreover, in the chronic AAA model, spironolactone treatment of pre-formed aneurysms significantly attenuated vascular inflammation and remodeling to attenuate the progression of AAAs compared to controls. Mechanistically, <jats:italic>in vitro<\/jats:italic> data demonstrated that spironolactone treatment attenuates extracellular ATP release from endothelial cells to mitigate macrophage activation (IL-1\u03b2 and HMGB1 expression) and smooth muscle cell-dependent vascular remodeling (MMP2 activity).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These results demonstrate that spironolactone can mitigate aortic inflammation and remodeling to attenuate AAA formation as well as decrease growth of pre-formed aneurysms <jats:italic>via<\/jats:italic> inhibition of EC-dependent ATP release. Therefore, this study implicates a therapeutic application of spironolactone in the treatment of AAAs.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2023.1101389","type":"journal-article","created":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T05:43:27Z","timestamp":1674711807000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Pharmacologic inhibition by spironolactone attenuates experimental abdominal aortic aneurysms"],"prefix":"10.3389","volume":"10","author":[{"given":"Zachary","family":"Ladd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Hartman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanyi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Hensley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Gilbert R.","family":"Upchurch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish K.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nrcardio.2011.1","article-title":"Diagnostic and therapeutic strategies for small abdominal aortic aneurysms.","volume":"8","author":"Klink","year":"2011","journal-title":"Nat Rev Cardiol."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-018-0030-7","article-title":"Abdominal aortic aneurysms.","volume":"4","author":"Sakalihasan","year":"2018","journal-title":"Nat Rev Dis Primers."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1056\/NEJMcp2108504","article-title":"Management of abdominal aortic aneurysms.","volume":"385","author":"Schanzer","year":"2021","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3650","DOI":"10.18632\/aging.101702","article-title":"Abdominal aortic aneurysm in aged population.","volume":"10","author":"Umebayashi","year":"2018","journal-title":"Aging (Albany NY)."},{"key":"B5","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/S0741-5214(03)00324-0","article-title":"Current concepts in the pathogenesis of abdominal aortic aneurysm.","volume":"38","author":"Ailawadi","year":"2003","journal-title":"J Vasc Surg."},{"key":"B6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0741-5214(92)90101-D","article-title":"Correlation of inflammatory infiltrate with the enlargement of experimental aortic aneurysms.","volume":"16","author":"Anidjar","year":"1992","journal-title":"J Vasc Surg."},{"key":"B7","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.avsg.2006.11.001","article-title":"Role of matrix metalloproteinase inhibitors in preventing abdominal aortic aneurysm.","volume":"21","author":"Aziz","year":"2007","journal-title":"Ann Vasc Surg."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1161\/01.ATV.15.8.1145","article-title":"Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm.","volume":"15","author":"Freestone","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.atherosclerosis.2020.02.009","article-title":"Nuclear receptors in abdominal aortic aneurysms.","volume":"297","author":"Neels","year":"2020","journal-title":"Atherosclerosis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1161\/CIRCRESAHA.118.312436","article-title":"Genetics of thoracic and abdominal aortic diseases.","volume":"124","author":"Pinard","year":"2019","journal-title":"Circ Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1067\/mva.2000.108010","article-title":"Increased matrix metalloproteinase 2 expression in vascular smooth muscle cells cultured from abdominal aortic aneurysms.","volume":"32","author":"Crowther","year":"2000","journal-title":"J Vasc Surg."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jvs.2006.06.036","article-title":"Effects of tissue inhibitor of metalloproteinase 2 deficiency on aneurysm formation.","volume":"44","author":"Xiong","year":"2006","journal-title":"J Vasc Surg."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29233-4","article-title":"Endothelial pannexin-1 channels modulate macrophage and smooth muscle cell activation in abdominal aortic aneurysm formation.","volume":"13","author":"Filiberto","year":"2022","journal-title":"Nat Commun."},{"key":"B14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.bbamem.2012.01.017","article-title":"The biochemistry and function of pannexin channels.","volume":"1828","author":"Penuela","year":"2013","journal-title":"Biochim Biophys Acta."},{"key":"B15","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1124\/jpet.108.146365","article-title":"Pharmacological characterization of pannexin-1 currents expressed in mammalian cells.","volume":"328","author":"Ma","year":"2009","journal-title":"J Pharmacol Exp Ther."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8965","article-title":"Pannexin 1 channels regulate leukocyte emigration through the venous endothelium during acute inflammation.","volume":"6","author":"Lohman","year":"2015","journal-title":"Nat Commun."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/jcp.24563","article-title":"Functional role of connexins and pannexins in the interaction between vascular and nervous system.","volume":"229","author":"Gaete","year":"2014","journal-title":"J Cell Physiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1124\/jpet.114.220210","article-title":"Contribution of pannexin 1 and connexin 43 hemichannels to extracellular calcium-dependent transport dynamics in human blood-brain barrier endothelial cells.","volume":"353","author":"Kaneko","year":"2015","journal-title":"J Pharmacol Exp Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.immuni.2007.03.008","article-title":"Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling.","volume":"26","author":"Kanneganti","year":"2007","journal-title":"Immunity."},{"key":"B20","doi-asserted-by":"publisher","first-page":"L301","DOI":"10.1152\/ajplung.00004.2018","article-title":"Pannexin-1 channels on endothelial cells mediate vascular inflammation during lung ischemia-reperfusion injury.","volume":"315","author":"Sharma","year":"2018","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41586-020-2121-3","article-title":"Metabolites released from apoptotic cells act as tissue messengers.","volume":"580","author":"Medina","year":"2020","journal-title":"Nature."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.64787","article-title":"ATP and large signaling metabolites flux through caspase-activated Pannexin 1 channels.","volume":"10","author":"Narahari","year":"2021","journal-title":"eLife."},{"key":"B23","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1161\/CIRCRESAHA.117.312380","article-title":"Pannexin 1 channels as an unexpected new target of the anti-hypertensive drug spironolactone.","volume":"122","author":"Good","year":"2018","journal-title":"Circ Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"H1055","DOI":"10.1152\/ajpheart.00651.2020","article-title":"Pannexin 1 channels control the hemodynamic response to hypoxia by regulating O2-sensitive extracellular ATP in blood.","volume":"320","author":"Kirby","year":"2021","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01531","article-title":"Purinergic cooperation between P2Y2 and P2X7 receptors promote cutaneous leishmaniasis control: involvement of pannexin-1 and leukotrienes.","volume":"9","author":"Thorstenberg","year":"2018","journal-title":"Front Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1161\/ATVBAHA.116.307373","article-title":"Mesenchymal stem cells attenuate NADPH oxidase-dependent high mobility group box 1 production and inhibit abdominal aortic aneurysms.","volume":"36","author":"Sharma","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1161\/CIRCULATIONAHA.113.006800","article-title":"Inhibition of interleukin-1beta decreases aneurysm formation and progression in a novel model of thoracic aortic aneurysms.","volume":"130","author":"Johnston","year":"2014","journal-title":"Circulation."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jss.2012.04.073","article-title":"Differential gender- and species-specific formation of aneurysms using a novel method of inducing abdominal aortic aneurysms.","volume":"178","author":"Laser","year":"2012","journal-title":"J Surg Res."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201701138RR","article-title":"Human mesenchymal stromal cell-derived extracellular vesicles attenuate aortic aneurysm formation and macrophage activation via microRNA-147.","volume":"32","author":"Spinosa","year":"2018","journal-title":"FASEB J"},{"key":"B30","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1161\/CIRCULATIONAHA.111.083451","article-title":"Experimental abdominal aortic aneurysm formation is mediated by IL-17 and attenuated by mesenchymal stem cell treatment.","volume":"126","author":"Sharma","year":"2012","journal-title":"Circulation."},{"key":"B31","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S0741-5214(03)00125-3","article-title":"Transient exposure to elastase induces mouse aortic wall smooth muscle cell production of MCP-1 and RANTES during development of experimental aortic aneurysm.","volume":"38","author":"Colonnello","year":"2003","journal-title":"J Vasc Surg."},{"key":"B32","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jvs.2016.07.105","article-title":"A novel chronic advanced stage abdominal aortic aneurysm murine model.","volume":"66","author":"Lu","year":"2017","journal-title":"J Vasc Surg."},{"key":"B33","doi-asserted-by":"publisher","first-page":"9787","DOI":"10.1096\/fj.202000251R","article-title":"Pharmacologic inhibition of transient receptor channel vanilloid 4 attenuates abdominal aortic aneurysm formation.","volume":"34","author":"Shannon","year":"2020","journal-title":"FASEB J."},{"key":"B34","doi-asserted-by":"publisher","first-page":"11303","DOI":"10.1074\/jbc.M111.323378","article-title":"Pannexin 1, an ATP release channel, is activated by caspase cleavage of its pore-associated C-terminal autoinhibitory region.","volume":"287","author":"Sandilos","year":"2012","journal-title":"J Biol Chem."},{"key":"B35","doi-asserted-by":"publisher","first-page":"6436","DOI":"10.1073\/pnas.0611280104","article-title":"The role of pannexin 1 hemichannels in ATP release and cell-cell communication in mouse taste buds.","volume":"104","author":"Huang","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"key":"B36","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41594-020-0401-0","article-title":"Cryo-EM structures of the ATP release channel pannexin 1.","volume":"27","author":"Deng","year":"2020","journal-title":"Nat Struct Mol Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"C832","DOI":"10.1152\/ajpcell.00053.2020","article-title":"Purinergic signaling, DAMPs, and inflammation.","volume":"318","author":"Di Virgilio","year":"2020","journal-title":"Am J Physiol Cell Physiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41568-018-0037-0","article-title":"Extracellular ATP and P2 purinergic signalling in the tumour microenvironment.","volume":"18","author":"Di Virgilio","year":"2018","journal-title":"Nat Rev Cancer."},{"key":"B39","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/414916a","article-title":"Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage.","volume":"414","author":"Ohta","year":"2001","journal-title":"Nature."},{"key":"B40","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.immuni.2015.10.009","article-title":"Caspase-11 requires the pannexin-1 channel and the purinergic P2X7 pore to mediate pyroptosis and endotoxic shock.","volume":"43","author":"Yang","year":"2015","journal-title":"Immunity."},{"key":"B41","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1161\/ATVBAHA.112.300432","article-title":"Genetic and pharmacologic disruption of interleukin-1beta signaling inhibits experimental aortic aneurysm formation.","volume":"33","author":"Johnston","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2005824","article-title":"A molecular signature in the pannexin1 intracellular loop confers channel activation by the alpha1 adrenoreceptor in smooth muscle cells.","volume":"8","author":"Billaud","year":"2015","journal-title":"Sci Signal."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.febslet.2015.03.018","article-title":"Pannexin 1 facilitates arterial relaxation via an endothelium-derived hyperpolarization mechanism.","volume":"589","author":"Gaynullina","year":"2015","journal-title":"FEBS Lett."},{"key":"B44","first-page":"963","article-title":"Mineralocorticoid receptor antagonists and endothelial function.","volume":"9","author":"Maron","year":"2008","journal-title":"Curr Opin Investig Drugs."},{"key":"B45","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.jss.2013.05.002","article-title":"Protective effects of selective mineralocorticoid receptor antagonist against aortic aneurysm progression in a novel murine model.","volume":"185","author":"Kurobe","year":"2013","journal-title":"J Surg Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jvs.2018.09.057","article-title":"A novel swine model of abdominal aortic aneurysm.","volume":"70","author":"Cullen","year":"2019","journal-title":"J Vasc Surg."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1101389\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T05:43:30Z","timestamp":1674711810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1101389\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,26]]},"references-count":46,"alternative-id":["10.3389\/fcvm.2023.1101389"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2023.1101389","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,26]]},"article-number":"1101389"}}